Loading this company
Insulet Corporation
PODDPrices in USD
TickerWorth ScoreC51/100
What we think
Too wide to call. Our lenses land between $57.92 and $157.95, which is too broad to say where today’s price sits in it.
Price
$141.10USD up +$2.33 (+1.68%)
Quoted · Prices are delayed.
Why did it move today?
Nothing we can cite explains today’s move for this company.
Is it cheap?
Our range from 3 models, on today’s numbers
$57.92–$157.95
What the price needs: revenue growth of more than 25%/yr for 5 years (our model assumes 13.9%), or investors accepting a ~6.6% discount rate, vs the 9.9% our model uses.
Led by discounted cash flow (DCF) · Steady cash-flow business
Price $141.10Priced · Prices are delayed.
Is it a good business?
- Valuation17 out of 100
- Growth100 out of 100
- Financial health83 out of 100
- Past performance67 out of 100
Bull, base, bear
Our forward range over 12 months is part of Pro. See plans
The street
Analysts’ mean target
$167.17 across 23 analysts
The high and low of the analyst range is part of Pro. See plans
What does it do?
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It operates in the Medical Devices industry (Healthcare sector), headquartered in United States. The company employs roughly 5,400 people.
Key stats
52-week range$126.40–$354.88
- Open
- $140.46
- Day high
- $143.30
- Day low
- $140.23
- Previous close
- $138.77
- Volume
- 1,618,308 · 0.95× avg
- Average volume
- 1,695,098
- Market cap
- $9,785,878,528.00
- P/E (TTM)
- 26.42
- Earnings per share
- $5.34
- Beta
- 1.10
Prices are delayed. The feed does not say when these figures were taken.
What’s the latest?
- Signed a material agreement
- Changed leadership or its board
- Changed leadership or its board
- Reported quarterly or annual results
- Changed leadership or its board
- Issued a public disclosure (Reg FD)
- Amended its charter or bylaws
Top news
No recent headlines we can cite for this company.
Insider trades
The 90-day buying-and-selling read is part of Pro. See plans
- Pease FlaviaShares withheld (tax) · $246,146.78
- MAZELSKY JONATHAN JAYGrant / award ·
Not investment advice. TickerWorth Score is a model output.